LAS VEGAS - nvtip -- InfoWerks Awarded $190,000 Grant from NCPDP Foundation to Streamline REMS Process

InfoWerks, a leading provider of healthcare data management solutions, has been awarded a $190,000 grant from the NCPDP Foundation to lead a groundbreaking project aimed at streamlining data exchange for the FDA's Risk Evaluation and Mitigation Strategy (REMS) plan. The project will leverage the REMS transaction within the NCPDP SCRIPT standard to enhance patient safety and reduce administrative burdens by minimizing manual processing delays.

Jeff Deitch, Chief Executive Officer at InfoWerks, expressed his enthusiasm: "Receiving this grant from the NCPDP Foundation is incredibly exciting. It propels us toward our goal of enhancing patient safety by streamlining the REMS process. With this support, we can empower patients and pharmacists alike, ensuring timely access to accurate data and promoting informed medication management."

More on nvtip.com

• Sustainable Energy Brand EBL to Unveil New Brand Identity and Innovative Power Solutions at CES 2025
• The World's No.1 Superstar Is Celebrating His 21st Birthday for the 28th Time Today!
• Does Health Insurance Cover Dermatology?
• Who is Stan Fitzgerald Georgia Veterans for America First state chapter Political Director
• 4th Annual Pompano Fall Festival: Shirley Murdock, Adina Howard, Jeezy, and Plies Headline Broward County's Top Music Festival

The project will focus on collaborating with a pharmacy, a pharmacy management system vendor and a REMS administrator. This initiative aims to simplify REMS program implementation for pharmacies, improve patient information and monitoring, and empower healthcare providers to guide patients through the adoption of innovative or complex new treatments.

Kelee Petzelt, an industry consultant managing the project's testing and development, added, "The grant from the NCPDP Foundation is a game-changer for our project. It's not just about simplifying the REMS process; it's about revolutionizing the role of pharmacists in patient care. With real-time adjudication and streamlined workflows, we can elevate pharmacists to key stakeholders in ensuring the safe use of high-risk medications."

The use of the NCPDP SCRIPT standard in this project will ensure data accuracy, consistency, and security, which is fundamental to patient safety when dealing with high-risk medications and emerging therapies. By integrating standards-based data exchange into healthcare workflows and clinical decision-making, InfoWerks anticipates significant improvements in patient care and emerging therapy management.

More on nvtip.com

• San Francisco Bay Area Songwriting Duo Razteria and Dave Shul Release Retro Rock Pop Album Prowess Blossoming
• Spirit Airlines' Black & Yellow Friday Deals Take Off with $25 Flights, Free Spirit® Bonus Points and More
• Le trio français de Punk-Metal Psychédélique Joe La Truite signe un contrat de management international
• Help Disabled American Homeless Veteran Become Financially Independent
• Ultimate Spades Tour Launches Groundbreaking Series From Creators Mekhi Phifer And Lawrence Adisa On Thanksgiving 2024

This grant was made possible with support from the FDB Patient Safety Founder's Donor Fund, the GoodRx Access to Care Founder's Donor Fund, and the NCPDP Foundation General Grant Fund. The project aligns with three of the NCPDP Foundation's strategic initiatives: increasing patient access to care, expanding the role and value of pharmacists, and enhancing patient safety.

About InfoWerks

www.infowerks.com